Mibelle chief explains how latest technology has industry in a spin

By Simon Pitman

- Last updated on GMT

Dr. Fred Zŭlli, business unit manager for Mibelle Biochemistry explains how the company's latest technologically advanced offering has been difficult for some in the industry to fully digest.

The company's dermal stem cell technology was launched earlier this year, building on its industry leading apple stem cell technology to provide formulators with the power to create yet more effective anti-ageing formulations.

However, as Dr. Zŭlli explains, just as the industry was getting its head around the major advancement represented by the apple stem cell technology, the company's latest development is said to have been difficult to digest for some in the industry.

Despite this, Dr. Zŭlli share with CosmeticsDesign-Europe.com his belief that it will just be a matter of time before a higher level of industry acceptance is achieved, by which time the company is aiming to further build on the strength of its world-renowned reputation.

Related topics: Formulation & Science

Related news

Show more